{"filing":{"accession_number":"0001493152-26-032932","cik":"0002064764","ticker":"PLSM","company_name":"Pulsenmore Ltd.","form":"6-K","filing_date":"2026-07-13","report_date":null,"primary_document":"form6-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/2064764/000149315226032932/form6-k.htm"},"events":[{"id":17487,"run_id":15663,"accession_number":"0001493152-26-032932","anchor_item_number":"EX-99.1","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.75,"summary":"Pulsenmore announced its selection for Israel's Healthcare AI Regulatory Sandbox Program with $1 million in funding to develop and clinically validate AI applications for its home ultrasound platform. This is a material operational and strategic milestone—a government-backed program that advances the company's product roadmap, expands its clinical validation capabilities, and establishes a regulatory pathway for AI integration. While not a discrete event type like M\u0026A or exec change, it represents a significant operational development that would affect a reasonable investor's assessment of the company's growth trajectory and competitive positioning.","company_name":"Pulsenmore Ltd.","ticker":"PLSM","filing_date":"2026-07-13","form":"6-K","submitted_at":null,"items":[{"id":15983,"accession_number":"0001493152-26-032932","item_number":"EX-99.1","item_title":"ex99-1.htm","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.75,"reasoning":"Pulsenmore announced its selection for Israel's Healthcare AI Regulatory Sandbox Program with $1 million in funding to develop and clinically validate AI applications for its home ultrasound platform. This is a material operational and strategic milestone—a government-backed program that advances the company's product roadmap, expands its clinical validation capabilities, and establishes a regulatory pathway for AI integration. While not a discrete event type like M\u0026A or exec change, it represents a significant operational development that would affect a reasonable investor's assessment of the company's growth trajectory and competitive positioning.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-07-13T11:38:37.688934+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":15983,"accession_number":"0001493152-26-032932","item_number":"EX-99.1","item_title":"ex99-1.htm","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.75,"reasoning":"Pulsenmore announced its selection for Israel's Healthcare AI Regulatory Sandbox Program with $1 million in funding to develop and clinically validate AI applications for its home ultrasound platform. This is a material operational and strategic milestone—a government-backed program that advances the company's product roadmap, expands its clinical validation capabilities, and establishes a regulatory pathway for AI integration. While not a discrete event type like M\u0026A or exec change, it represents a significant operational development that would affect a reasonable investor's assessment of the company's growth trajectory and competitive positioning.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-07-13T11:38:37.688934+00:00","company_name":"Pulsenmore Ltd.","ticker":"PLSM","filing_date":"2026-07-13"}]}